 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Tammenoms Bakker Juliet
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2016-03-29 Purchase | 2016-03-31 4:59 pm | Aimmune Therapeutics Inc. | AIMT | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 78,504 | $13.87 | $1,089,135 | 7,513,134 (Indirect) | View |
| 2016-11-15 Sale | 2016-11-17 7:32 pm | CORCEPT THERAPEUTICS INC | CORT | Longitude Venture Partners L.P. Longitude Capital Associates L.P. Longitude Capital Partners LLC Tammenoms Bakker Juliet 10% Owner | 174,847 | $9.549 | $1,669,606 | 191,522 (Indirect Direct) | View |
| 2016-11-17 Sale | 2016-11-21 9:10 pm | CORCEPT THERAPEUTICS INC | CORT | Longitude Venture Partners L.P. Longitude Capital Partners LLC Tammenoms Bakker Juliet Longitude Capital Associates L.P. 10% Owner | 544,100 | $9.556 | $5,199,426 | 180,830 (Indirect Direct) | View |
| 2016-11-22 Sale | 2016-11-25 9:08 pm | CORCEPT THERAPEUTICS INC | CORT | Longitude Venture Partners L.P. Longitude Capital Partners LLC Tammenoms Bakker Juliet Longitude Capital Associates L.P. 10% Owner | 36,941 | $9.3437 | $345,165 | 180,103 (Indirect Direct) | View |
| 2017-07-25 Purchase | 2017-07-27 5:23 pm | Kala Pharmaceuticals Inc. | KALA | Longitude Capital Partners II LLC ENRIGHT PATRICK G Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 215,000 | $15 | $3,225,000 | 2,270,946 (Indirect) | View |
| 2017-12-08 Sale | 2017-12-12 4:20 pm | COLLEGIUM PHARMACEUTICAL INC | COLL | Longitude Capital Partners LLC Tammenoms Bakker Juliet ENRIGHT PATRICK G Longitude Capital Associates L.P. Longitude Venture Partners L.P. 10% Owner | 1,000,000 | $17.34 | $17,340,000 | 45,620 (Indirect) | View |
| 2018-02-22 Purchase | 2018-02-26 4:25 pm | Aimmune Therapeutics Inc. | AIMT | Tammenoms Bakker Juliet 10% Owner | 9,375 | $32 | $300,000 | 16,651 (Indirect Direct) | View |
| 2018-06-25 Purchase | 2018-06-26 4:55 pm | Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 150,000 | $16 | $2,400,000 | 3,190,079 (Indirect) | View |
| 2018-07-02 Purchase | 2018-07-02 9:16 pm | Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 131,579 | $19 | $2,500,001 | 3,019,734 (Indirect) | View |
| 2018-09-21 Purchase | 2018-09-25 4:43 pm | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 365,000 | $5.5 | $2,007,500 | 3,261,535 (Indirect) | View |
| 2018-11-02 Purchase | 2018-11-02 7:28 pm | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 533,333 | $15 | $7,999,995 | 2,933,333 (Indirect) | View |
| 2019-11-11 Purchase | 2019-11-13 7:02 pm | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 575,000 | $16 | $9,200,000 | 575,000 (Indirect) | View |
| 2019-11-25 Purchase | 2019-11-27 4:47 pm | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 937,000 | $8 | $7,496,000 | 4,198,535 (Indirect) | View |
| 2019-11-25 Purchase(A) | 2019-12-05 4:16 pm | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 937,500 | $8 | $7,500,000 | 4,199,035 (Indirect) | View |
| 2020-07-10 Purchase | 2020-07-14 8:11 pm | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 109,090 | $27.5 | $2,999,975 | 2,600,877 (Indirect) | View |
| 2020-07-28 Purchase | 2020-07-28 6:20 pm | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 625,000 | $16 | $10,000,000 | 2,819,379 (Indirect) | View |
| 2020-08-14 Sale | 2020-08-18 5:32 pm | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director | 2,393 | $43.22 | $103,422 | 9,167 (Indirect Direct) | View |
| 2020-08-28 Sale | 2020-09-01 7:33 pm | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 3,496 | $10.75 | $37,568 | 0 (Indirect) | View |
| 2020-09-18 Sale | 2020-09-22 6:01 pm | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director | 9,167 | $42.67 | $391,119 | 3,500 (Indirect Direct) | View |
| 2020-10-20 Purchase | 2020-10-22 7:53 pm | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 233,333 | $18 | $4,199,994 | 3,918,691 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2016-11-28 Other | 2016-11-30 9:52 pm | N/A N/A | CORCEPT THERAPEUTICS INC | CORT | Longitude Venture Partners L.P. Longitude Capital Partners LLC Tammenoms Bakker Juliet Longitude Capital Associates L.P. 10% Owner | 2,941,050 | $0 | 121,153 (Direct) | View |
| 2016-11-28 Other | 2016-11-30 9:52 pm | N/A N/A | CORCEPT THERAPEUTICS INC | CORT | Longitude Venture Partners L.P. Longitude Capital Partners LLC Tammenoms Bakker Juliet Longitude Capital Associates L.P. 10% Owner | 58,950 | $0 | 121,153 (Indirect) | View |
| 2016-11-29 Other | 2016-12-01 9:50 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 1,500,000 | $0 | 7,276 (Indirect) | View |
| 2016-11-29 Other | 2016-12-01 9:50 pm | N/A N/A | Aimmune Therapeutics Inc. | AIMT | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 7,276 | $0 | 7,276 (Direct) | View |
| 2016-12-12 Other | 2016-12-14 8:28 pm | N/A N/A | CORCEPT THERAPEUTICS INC | CORT | Tammenoms Bakker Juliet 10% Owner | 204,210 | $0 | 204,210 (Direct) | View |
| 2016-12-15 Gift | 2016-12-19 1:29 pm | N/A N/A | CORCEPT THERAPEUTICS INC | CORT | Tammenoms Bakker Juliet 10% Owner | 70,671 | $0 | 133,539 (Direct) | View |
| 2017-07-25 Conversion | 2017-07-27 5:23 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Longitude Capital Partners II LLC ENRIGHT PATRICK G Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 2,055,946 | $0 | 2,270,946 (Indirect) | View |
| 2017-07-25 Conversion | 2017-07-27 5:23 pm | N/A N/A | Kala Pharmaceuticals Inc. | KALA | Longitude Capital Partners II LLC ENRIGHT PATRICK G Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 10,707,985 | $0 | 2,270,946 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:55 pm | N/A N/A | Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 1,047,450 | $0 | 3,190,079 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:55 pm | N/A N/A | Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 1,197,076 | $0 | 3,190,079 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:55 pm | N/A N/A | Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 795,553 | $0 | 3,190,079 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:55 pm | N/A N/A | Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 28,895,188 | $0 | 3,190,079 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:55 pm | N/A N/A | Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 33,022,786 | $0 | 3,190,079 (Indirect) | View |
| 2018-06-25 Conversion | 2018-06-26 4:55 pm | N/A N/A | Aptinyx Inc. | APTX | Longitude Capital Partners II LLC Tammenoms Bakker Juliet Longitude Venture Partners II L.P. 10% Owner | 21,946,300 | $0 | 3,190,079 (Indirect) | View |
| 2018-07-02 Conversion | 2018-07-02 9:16 pm | N/A N/A | Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 2,431,511 | $0 | 3,019,734 (Indirect) | View |
| 2018-07-02 Conversion | 2018-07-02 9:16 pm | N/A N/A | Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 456,644 | $0 | 3,019,734 (Indirect) | View |
| 2018-07-02 Conversion | 2018-07-02 9:16 pm | N/A N/A | Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 9,677,419 | $0 | 3,019,734 (Indirect) | View |
| 2018-07-02 Conversion | 2018-07-02 9:16 pm | N/A N/A | Tricida Inc. | TCDA | Longitude Capital Partners II LLC Longitude Venture Partners II L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,817,447 | $0 | 3,019,734 (Indirect) | View |
| 2018-11-02 Conversion | 2018-11-02 7:28 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 2,400,000 | $0 | 2,933,333 (Indirect) | View |
| 2018-11-02 Conversion | 2018-11-02 7:28 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 2,000,000 | $0 | 2,933,333 (Indirect) | View |
| 2018-12-06 Option Award | 2018-12-10 9:17 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 2,500 | $0 | 5,000 (Direct) | View |
| 2018-12-06 Option Award | 2018-12-10 9:17 pm | N/A 2028-12-06 | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 5,000 | $14.8 | 5,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 7:27 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 1,667 | $0 | 5,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-07-01 7:27 pm | N/A 2029-06-27 | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 5,000 | $37.15 | 5,000 (Direct) | View |
| 2019-06-27 Option Award | 2019-08-15 7:58 pm | N/A 2029-06-27 | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 3,333 | $37.15 | 3,333 (Direct) | View |
| 2019-08-22 Option Award | 2019-08-26 6:58 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 5,000 | $0 | 10,000 (Direct) | View |
| 2019-08-22 Option Award | 2019-08-26 6:58 pm | N/A 2029-08-22 | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director 10% Owner | 10,000 | $34.1 | 10,000 (Direct) | View |
| 2019-11-07 Option Award | 2019-11-07 9:51 pm | N/A N/A | Venus Concept Inc. | VERO | Tammenoms Bakker Juliet Director 10% Owner | 3,476,584 | $0 | 8,650 (Indirect) | View |
| 2019-11-07 Option Award | 2019-11-07 9:51 pm | N/A N/A | Venus Concept Inc. | VERO | Tammenoms Bakker Juliet Director 10% Owner | 189,535 | $0 | 8,650 (Indirect) | View |
| 2019-11-07 Option Award | 2019-11-07 9:51 pm | N/A 2027-03-06 | Venus Concept Inc. | VERO | Tammenoms Bakker Juliet Director 10% Owner | 17,301 | $5.25 | 8,650 (Direct) | View |
| 2019-11-07 Option Award | 2019-11-07 9:51 pm | N/A 2027-03-06 | Venus Concept Inc. | VERO | Tammenoms Bakker Juliet Director 10% Owner | 8,650 | $5.25 | 8,650 (Direct) | View |
| 2019-11-11 Conversion | 2019-11-13 7:02 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,916,787 | $0 | 575,000 (Indirect) | View |
| 2019-11-11 Conversion | 2019-11-13 7:02 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 11,916,667 | $0 | 575,000 (Indirect) | View |
| 2020-01-29 Conversion | 2020-01-31 5:45 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,477,320 | $0 | 0 (Indirect) | View |
| 2020-01-29 Conversion | 2020-01-31 5:45 pm | N/A N/A | Sierra Oncology Inc. | SRRA | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 19,500 | $0 | 0 (Indirect) | View |
| 2020-05-26 Other | 2020-05-28 9:07 pm | N/A N/A | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 1,000,000 | $0 | 1,049 (Indirect) | View |
| 2020-05-26 Other | 2020-05-28 9:07 pm | N/A N/A | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 3,495 | $0 | 1,049 (Indirect) | View |
| 2020-05-26 Other | 2020-05-28 9:07 pm | N/A N/A | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 2,447 | $0 | 1,049 (Indirect) | View |
| 2020-05-26 Other | 2020-05-28 9:07 pm | N/A N/A | Molecular Templates Inc. | MTEM | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. ENRIGHT PATRICK G Tammenoms Bakker Juliet 10% Owner | 1,049 | $0 | 1,049 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-28 6:20 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 2,007,225 | $0 | 2,819,379 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-28 6:20 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 187,154 | $0 | 2,819,379 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-28 6:20 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 15,000,000 | $0 | 2,819,379 (Indirect) | View |
| 2020-07-28 Conversion | 2020-07-28 6:20 pm | N/A N/A | Inozyme Pharma Inc. | INZY | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 1,398,600 | $0 | 2,819,379 (Indirect) | View |
| 2020-08-10 Other | 2020-08-12 8:10 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director | 978,000 | $0 | 11,560 (Indirect) | View |
| 2020-08-10 Other | 2020-08-12 8:10 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director | 1,026 | $0 | 11,560 (Indirect) | View |
| 2020-08-10 Other | 2020-08-12 8:10 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director | 2,393 | $0 | 11,560 (Direct) | View |
| 2020-08-24 Option Award | 2020-08-26 8:17 pm | N/A N/A | Axonics Modulation Technologies Inc. | AXNX | Tammenoms Bakker Juliet Director | 3,500 | $0 | 12,667 (Direct) | View |
| 2020-10-15 Option Award | 2020-10-19 6:07 pm | N/A 2030-10-14 | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 6,666 | $18 | 6,666 (Direct) | View |
| 2020-10-20 Conversion | 2020-10-22 7:53 pm | N/A N/A | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 3,685,358 | $0 | 3,918,691 (Indirect) | View |
| 2020-10-20 Conversion | 2020-10-22 7:53 pm | N/A N/A | Eargo Inc. | EAR | Tammenoms Bakker Juliet Director 10% Owner | 3,685,358 | $0 | 3,918,691 (Indirect) | View |
| 2020-11-16 Other | 2020-11-18 7:11 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 850,000 | $0 | 891 (Indirect) | View |
| 2020-11-16 Other | 2020-11-18 7:11 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 2,973 | $0 | 891 (Indirect) | View |
| 2020-11-16 Other | 2020-11-18 7:11 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 2,080 | $0 | 891 (Indirect) | View |
| 2020-11-16 Other | 2020-11-18 7:11 pm | N/A N/A | 89bio Inc. | ETNB | Longitude Capital Partners III LLC Longitude Venture Partners III L.P. Tammenoms Bakker Juliet ENRIGHT PATRICK G 10% Owner | 891 | $0 | 891 (Indirect) | View |